The ovulatory process in cyclic rats was studied after prostanoid synthesis was blocked using indomethacin. Animals were injected at 12:00 h in pro-oestrus with 1.0 mg indomethacin or vehicle (olive oil) and killed at 18:30 h in pro-oestrus, at 02:00, 09:00 and 19:00 h in oestrus and at 09:00 h in metoestrus. Additional rats injected with 0.5 or 4.0 mg indomethacin were killed at 09:00 h in oestrus. No differences in either morphology or serum LH concentrations were found between vehicle or indomethacin-treated rats at 18:30 h in pro-oestrus. However, from 02:00 h in oestrus onward, the process of follicle rupture was altered considerably in indomethacintreated rats, irrespective of the dose. Early vascular changes, observed in control rats at the apex of the follicle, were absent in indomethacin-treated rats. In some follicles, disruption of the theca layers, invasion of the perifollicular tissue by granulosa cells and follicular fluid, and release of the oocyte to the ovarian interstitium were observed at 02:00 h in oestrus. A small number of follicles ruptured at the ovarian surface. Furthermore, invasion of interstitial tissue, rupture of blood vessel walls, production of emboli of granulosa cells and follicular fluid, and inflammatory reactions were observed in oestrus and metoestrus. The results of the present study demonstrate uncontrolled proteolytic activity, and indicate that abnormal follicle rupture (but not inhibition of follicle rupture) is responsible for ovulation failure in indomethacin-treated rats.
Introduction
During ovulation, the ovarian tissues located between the oocyte and the ovarian surface (including two basement membranes and the collagenous tissue of the theca and tunica albuginea) have to be degraded. The current view of ovulation is that the preovulatory LH surge initiates an inflammatorylike reaction that leads ultimately to the activation of tissue matrix-degrading enzymes. The subsequent degradation of collagenous tissue at the apex of the follicle allows release of the cumulus containing the oocyte, under the force of a modest, but effective, intrafollicular pressure (Espey, 1980 (Espey, , 1994 (Espey, , 1998 Tsafriri et al., 1993; Espey and Lipner, 1994) .
Eicosanoids, the active products of arachidonic acid metabolism, have been widely considered to play a key role in ovulation (Brännström and Janson, 1991; Tsafriri et al., 1993; Espey, 1994; Espey and Lipner, 1994) . Evidence for involvement of prostanoids in the ovulatory process is derived, at least in part, from the repeated observation that indomethacin, a powerful inhibitor of cyclooxygenase, inhibits ovulation in several species (Brännström and Janson, 1991; Tsafriri et al., 1993; Espey and Lipner, 1994) . In rats, indomethacin blocks ovulation over a broad period of time, from 10 h before to 13 h after hCG administration (Tanaka et al., 1992) .
The anti-ovulatory action of indomethacin seems not to be due to secondary effects via other organs. Experiments with ovaries perfused in vitro (Hamada et al., 1977; Holmes et al., 1983) demonstrated that indomethacin blocks ovulation via direct actions on the ovary. However, the mechanisms of the anti-ovulatory effect of indomethacin are not known. Biochemical studies on proteolytic activity also provided contradictory results. Whereas some studies reported inhibition of collagenolytic activity in indomethacintreated animals (Reich et al., 1985a (Reich et al., , 1991 Murdoch and McCormick, 1991) , other studies found that collagenolytic activity was not affected (Curry et al., 1986; Tanaka et al., 1992) .
In spite of the large number of studies using indomethacin to block ovulation, morphological studies are scarce. Detailed structural studies in mice (Downs and Longo, 1982, 1983) , rats (Parr, 1974) and rabbits (Espey et al., 1981) have been limited to the apex of the follicle, and have also provided contradictory results.
The blocking effect of indomethacin on follicle rupture in most cases has been deduced indirectly by counting oocytes in the oviducts on the morning of oestrus or in the perfusion chamber in studies in vitro (Shimada et al., 1983; Reich et al., 1985a; Mikuni et al., 1998). However, Osman and Dullaart (1976) suggested that the processes of follicle rupture (that is, the breakdown of the follicle wall) and ovulation (that is, the release of mature oocytes from the Morphological evidence for uncontrolled proteolytic activity during the ovulatory process in indomethacin-treated rats ovary) may be dissociated in indomethacin-treated rats. These authors reported the presence of eggs in the dense extrafollicular tissue, beneath the tunica albuginea, close to luteinized follicles in oestrus. This finding has been scarcely considered in the literature, and has been interpreted thereafter as a consequence of the differential effects of indomethacin on collagenase activities; the undisturbed action of collagenase IV would allow disruption of the basement membrane and escape of the oocyte from the follicular antrum, whereas inhibition of interstitial collagenase would prevent degradation of the collaganous tissue of the theca and tunica albuginea (Reich et al., 1991; Tsafriri et al., 1993) . In this context, the morphological characteristics of mature follicles during the ovulatory process in indomethacintreated rats are not clear. The aim of the present study was to analyse the morphological changes in the ovaries of indomethacin-treated cyclic rats during the periovulatory period to help clarify the still undefined role of prostanoids in ovulation.
Materials and Methods
Adult cyclic Wistar rats were maintained under controlled light (14 h light :10 h dark, lights on at 05:00 h) and temperature conditions, and had free access to rat chow and tap water. Vaginal smears were taken each day, and only animals displaying at least two consecutive 4 day oestrous cycles were used. Experiments were performed according to the Guide for Care and Use of Laboratory Animals, and were approved by the Ethical Committee of the University of Córdoba.
Rats were injected s.c. at 12:00 h in pro-oestrus with 0.5, 1.0 or 4.0 mg indomethacin (IM, Sigma Chemical Co., St Louis, MO) in olive oil or vehicle (200 µl). Rats injected with 1.0 mg indomethacin or with vehicle were killed at 18:30 h in pro-oestrus (ten animals per group), at 02:00, 09:00 and 19:00 h in oestrus and at 09:00 h in metoestrus (five animals per group). Rats injected with 0.5 and 4.0 mg indomethacin were killed at 09:00 h in oestrus (five and three animals per group, respectively).
Ovaries were dissected and fixed in Bouin-Hollande's fluid for at least 24 h and processed for embedding in paraffin wax. Serial sections (5 µm) were cut and stained with alcian blue-haematoxylin and eosin, and scored systematically under the microscope. The percentages of the different types of luteinized follicles-corpora lutea were determined at 09:00 h in oestrus, by two independent, blind to the treatment, observers. Inter-observer variation was negligible.
LH concentrations, at the expected time of the preovulatory surge (18:30 h on the evening of proestrus in our colony; Gaytán et al., 1997a) , were determined by radioimmunoassay in rats injected with 1.0 mg indomethacin or vehicle (ten animals per group) in trunk blood collected at the time of death, using the microassay method described by Sánchez-Criado et al. (1993) .
Results
In control rats, preovulatory follicles showed the expected maturational changes (Vermeiden and Zeilmaker, 1974; Gaytán et al., 1997b) . At 18:30 h on the evening of prooestrus, the oocyte was in the germinal vesicle stage, the cumulus was compact, and the granulosa cell layer was well organized (Fig. 1 ). Morphological differences were not found in indomethacin-treated rats, and LH concentrations, at the expected time of the preovulatory surge, were also equivalent (28.3 Ϯ 5.0 versus 26.5 Ϯ 5.0 ng ml -1 in control and indomethacin-treated rats, respectively; mean Ϯ SEM for n = 10).
At 02:00 h in oestrus, preovulatory follicles of control rats showed the characteristic LH-induced changes. The cumulus was dispersed and the oocyte was free in the antral cavity, surrounded by the corona radiata cells and was in telophase I, showing formation of the first polar body (Fig. 2a) . The theca cell layer showed infoldings and vascular congestion (Fig. 2 ). The granulosa cell layer was somewhat disorganized, and oedema and loosening of the connective tisue of the tunica albuginea and underlying ovarian stroma, with increased extracellular space, was observed at the apex of the follicle (Fig. 2a,b) . In mature follicles of indomethacin-treated rats, maturational changes at the cumulus and resumption of the meiotic process were equivalent to those of control rats (Fig.  3a) . However, large differences were found at the follicle wall. Oedema and loosening of connective tissues at the apex of the follicle were not detectable (Fig. 3a) . The limits between the granulosa and theca layers were indistinct and granulosa cells were invading the theca layer (Fig. 3b,c) . Some granulosa cells showed elongated nuclei and were in contact with the interstitial tissue (Fig. 3c ). Serial sections demonstrated that invasion of the theca layer ocurred at several points of the follicle wall. A variable number of follicles (from 20 to 50%) had completed follicle rupture, and granulosa cells and follicular fluid went across a gap in the theca layer, invading the ovarian interstitium ( Fig. 4a-d) . In some follicles, the cumulus containing the oocyte was also found in the interstitium (Fig. 4e) . A small number of follicles (from 5 to 20%) showed rupture at the ovarian surface (Fig. 5a ). In some of these follicles, a large area of the ovarian surface had been degraded (Fig. 5b) .
On the morning (09:00 h) of oestrus, control rats had newly formed corpora lutea that were not fully luteinized, and oocytes (in metaphase II) were found in the oviducts. In indomethacin-treated rats, follicles showed variable features. In some cases, the oocyte (in metaphase II) was retained in the follicular antrum. However, in these follicles, escape of granulosa cells and leakage of follicular fluid through gaps in the theca layer were observed, at several sites of the follicle wall (Fig. 6a) . In other cases, the oocyte surrounded by granulosa cells was found in interstitial lacunae (Fig. 6b) . Leucocyte margination was observed in the surrounding blood vessels (Fig. 6b) . Some follicles that were ruptured at the ovarian surface had nearly normal features, although some rupture points were observed in the border of the corpus luteum. Some oocytes were found in the oviducts. The most relevant feature at this time was the invasion of blood vessels by granulosa cells and follicular fluid. Although signs of blood vessel invasion were already apparent in some follicles at 02:00 h in oestrus (Fig. 4e) , this process was evident at 09:00 h in oestrus. Granulosa cells and follicular fluid eroded the blood vessel wall and produced emboli that were surrounded by polymorphonuclear leucocytes (Fig. 7) . Emboli of granulosa cells and follicular fluid were observed not only close to the point of rupture of the follicles (Fig. 7a-d) , but also at a distance, in central veins of the ovarian medula (Fig. 7e ). All the above described characteristics were observed with all three doses of indomethacin used. Quantitative data at 09:00 h in oestrus are presented (Table 1 ). More than 90% of luteinized follicles showed points of rupture of the wall. In about 44% of these follicles, the oocyte was entrapped, whereas in about 35% of the follicles, the oocyte was found 642 F. Gaytán et al. in the interstitium. In about 16% of the follicles, the oocyte had been released to the periovarian space. In a small percentage of follicles (< 8%), rupture points were not observed. Significant differences were not found for the different doses of indomethacin. The relationship between oocyte location and the distribution of rupture sites in indomethacin-treated rats is presented (Fig. 8) . Most luteinized follicles-corpora lutea in which the oocyte was entrapped, and about half of those in which the oocyte was released to the interstitium, showed several rupture sites on the basolateral or apical sides. On the evening (19:00 h) of oestrus, and on the morning (09:00 h) of metoestrus, control rats had well vascularized, luteinized corpora lutea. In indomethacin-treated rats, corpora lutea were also well vascularized and luteinized, irrespective of the presence or absence of an antral cavity. Oocytes were observed either inside corpora lutea or in the ovarian interstitium (Fig. 9a) . Clumps of luteinized granulosa cells, surrounded by inflammatory cells were observed (Fig.  9a ) in the vicinity of some corpora lutea. In blood vessels containing entrapped emboli, there were inflammatory cells around vessel walls. Granulosa cells, when present in emboli, were luteinized and had rounded nuclei and prominent nucleoli (Fig. 9b) .
Discussion
The proteolytic cascade, which is ultimately responsible for follicle rupture, should be tightly controlled, spatially targeted, and time limited, to assure efficient release of eggs and to prevent potential damage to the perifollicular ovarian tissues. Several studies have focused on the presence of different types of proteolytic activity and on its possible involvement in the ovulation. Increases in the activities of kalikrein (Espey et al., 1989) , plasminogen activator (Reich et al., 1985b; Chun et al., 1992; Hägglund et al., 1996) and matrix metalloproteinase (Curry et al., 1985 (Curry et al., , 1986 Reich et al., 1991; Liu et al., 1998; Curry and Osteen, 2001) have been demonstrated in the ovary during ovulation. These proteolytic activities are counteracted by the expression of different antiproteinases, such as plasminogen activator inhibitors (PAI-1 and -2) and tissue inhibitors of metalloproteinases (TIMPs) (Curry et al., 1990; Reich et al., 1991; Zhu and Woessner, 1991; Chun et al., 1992; Hägglund et al., 1996; Curry and Osteen, 2001 ). The present study documents follicle rupture in all indomethacin-treated rats, in agreement with the report of Osman and Dullaart (1976) that oocytes are released from adjacent luteinized follicles on the morning of oestrus. In the present study, disruption of the theca layers, invasion of the perifollicular tissue by granulosa cells and follicular fluid, rupture of blood vessel walls, and production of emboli of granulosa cells and follicular fluid were observed. These findings are the result of the proteolytic degradation of extracellular matrix and basement membranes, and constitute indirect, but unequivocal, evidence of uncon- trolled proteolytic activity. These findings are in agreement with previous functional studies indicating that indomethacin does not interfere with proteolytic activities, such as those of plasminogen activator (Shimada et al., 1983; Tanaka et al., 1992) or collagenase (Curry et al., 1986) .
The process of follicle rupture observed in indomethacintreated rats was altered in several ways. First, tissue degradation occurred earlier in indomethacin-treated than it did in control rats. This degradation was not likely to have been the result of an advanced preovulatory gonadotropin surge, as evidenced by the equivalent LH concentrations at 18:30 h on the evening of proestrus (the expected time of the preovulatory LH surge in our colony; Gaytán et al., 1997a) and by the synchronism in the meiotic process of the oocyte that follows a well established sequence after the 646 F. Gaytán et al.
LH surge (Vermeiden and Zeilmaker, 1974) . Furthermore, in indomethacin-treated rats, invasion of blood vessels seemed to continue some time after follicle rupture, whereas, in control rats, tissue degradation appeared to be finished after ovulation. This finding indicates that proteolytic enzyme activation lasts longer in indomethacintreated rats. Second, tissue degradation in indomethacin-treated rats was not limited to the apex of the follicle. Only a limited number of follicles (about 16%) showed rupture at the ovarian surface. Serial sections demonstrated that disruption of the theca and follicular fluid leakage occur at several points in the follicle wall, and the release of the oocyte seemed to occur at random, probably through the most advanced of these rupture points. This contention may explain the repeatedly reported presence of a limited number of oocytes in the oviducts, even with the higher indomethacin doses (Espey et al., 1986 (Espey et al., , 1989 Tanaka et al., 1989 ; present study) even though this drug inhibits ovulation in a dose-dependent manner (Murdoch and McCormick 1991; Tanaka et al., 1992) . Mice with targeted deletion of the prostaglandin synthase 2 gene that display ovulation impairment, also ovulated a limited number of ova (Russell and Richards, 1997) . At least some of the inconsistencies in the literature, with respect to the mechanisms of the antiovulatory effects of indomethacin, may be the result of the fact that the absence of oocytes in the oviducts does not provide valuable information about whether follicle rupture has occurred.
Third, early vascular changes (such as oedema and loosening of the tunica albuginea and the underlying ovarian stroma), observed at the apex of preovulatory follicles in control rats, were not visible in indomethacintreated rats. Similar changes were reported by Downs and Longo (1982, 1983) in indomethacin-treated mice. Although oedema of the collagenous tissue at the apex of the follicle was not present in indomethecin-treated rats, follicle rupture at the apex did occur in 15-20% of follicles. This finding indicates that these changes are not an absolute requirement for follicle rupture, at least in indomethacintreated rats. However, these changes presumably facilitate follicle rupture at the apex in control rats (Espey and Lipner, 1994; Espey, 1998) . 8 . Relationships between the location of oocyte and rupture sites in ruptured luteinized follicles-corpora lutea in indomethacin treated-rats at 09:00 h in oestrus. Luteinized follicles-corpora lutea were classified into three types, depending on the location of the oocyte (PS: oocyte released to periovarian space; I: oocyte released to interstitium; and CL: oocyte retained inside follicle), and into three classes, depending on the site of rupture (ᮀ: class A, showing only one rupture site at the apex; : class B, showing only one rupture site at the basolateral side; and : class C, showing several rupture sites at the basolateral side, possibly including a rupture site at the apex). Twenty-five luteinized follicles-corpora lutea of each type were scored, irrespective of the dose of indomethacin. Otherwise, oocytes were frequently retained inside the follicle, in spite of the gaps that occurred in the theca layer. There may be several reasons for this retention of oocytes. Intrafollicular pressure appears to play an important role in oocyte release (Espey, 1998) . However, when rupture occurs at the sides or the base of the follicle, the pressure gradient with respect to the dense interstitial tissue should Indomethacin and ovulation 647 be lower than it is with respect to the periovarian space. Furthermore, loss of granulosa cells and leakage of follicular fluid through small gaps in the follicle wall should decrease pressure in the follicular antrum. In addition, creating passageways through the dense ovarian stroma wide enough to allow release of the mucified cumulus containing the oocyte seemed not to be achieved in some follicles. However, most of the luteinized follicles in which the oocyte was entrapped showed several rupture sites. The results of the present study facilitate the proposal of a 'working hypothesis' about the mechanisms of the antiovulatory effects of indomethacin and the possible role of prostanoids in ovulation. The LH-initiated release of matrixdegrading enzymes by granulosa cells is counteracted by the release of proteinase inhibitors. The balance between activators and inhibitors of proteinase activity is tilted toward inhibition throughout the follicle wall, and prostanoids have a key role in maintaining this proteolytic inhibition. Under physiological conditions, the balance between proteolytic and antiproteolytic factors is tilted toward proteolysis at the apex of the follicle, probably by the release of activating factors by the tunica albuginea or the ovarian surface epithelium. In this context, the main effect of indomethacin seems to be the disruption of the inhibition of proteinase activity throughout the follicle wall, which is probably achieved by inhibiting the synthesis of one or more ovarian prostanoids. However, the existence of prostanoid-independent effects cannot be discarded. Indomethacin has effects on other mechanisms, such as Ca 2+ flux (Burch et al., 1983; Murdoch, 1996) , which is involved in many physiological processes. Therefore, the effects of indomethacin on ovulation may be exerted through inhibition of Ca 2+ flux. Further studies comparing the effects of indomethacin with those of other prostaglandin synthesis inhibitors that do not inhibit Ca 2+ flux (Burch et al., 1983) , as well as prostanoid replacement studies, are needed before definitive conclusions can be drawn. 
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